Asia Pacific Cryopreservation Equipment Market

The cryopreservation equipment market in Asia Pacific is expected to grow from US$ 906.02 million in 2022 to US$ 1,846.00 million by 2028; it is estimated to grow at a CAGR of 12.6% from 2022 to 2028.  

Cryopreservation playing a key role in the success of cell-based therapies is the major factor driving the growth of the Asia Pacific cryopreservation equipment market. Cryopreservation has become an important manufacturing process for many cellular therapies. It occasionally comes before cell culture (conserving the starting cellular material before moving forward with large-scale manufacturing) and generally follows cell expansion therapies. The ability to store cells at different points during the manufacturing process allows for creating a customized workflow. Cryopreservation can be employed in transplant manufacturing processes—a patient-specific therapy, such as autologous therapy, or an allogeneic therapy. The efficacy of immune cell-based cancer therapies depends on injecting highly viable cells after thawing; the injected cells can effectively detect and destroy target tumor cells.

Adopting best practices during manufacturing, such as selecting GMP-grade or suitable cryoprotective agents (CPA) and controlled-rate freezing equipment with appropriate cooling profiles for immune cells, helps generate high-quality cells. This guarantees the consistency of products and the effective functioning of cells. The cryopreservation of cell-based therapeutic products also aids in quarantining donor cells and final products, allowing for more extensive microbiological testing. Coordinating and transporting the final product in accordance with the patient's treatment plan and extending the final product's shelf life prior to patient administration. Thus, the importance of cryopreservation in the successful delivery of cell-based therapies boosts the use of cryopreservation equipment.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific cryopreservation equipment market. The Asia Pacific cryopreservation equipment market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Cryopreservation Equipment

Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Cryopreservation Equipment Market Segmentation   

Asia Pacific cryopreservation equipment market is segmented into type, cryogen type, application, end user, and country. Based on type, the cryopreservation equipment market is segmented into freezers, sample preparation systems, and accessories. The freezers segment is expected to lead the market in 2022. Based on the cryogen type, the Asia Pacific cryopreservation equipment market is segmented into liquid nitrogen, oxygen, liquid helium, argon, and others. In 2022, the liquid nitrogen segment is likely to hold the largest share of the market. The Asia Pacific cryopreservation equipment market, based on application, is segmented into cord blood stem cells, sperms, semen & testicular tissues, embryos and oocytes, cell and gene therapies, and others. The cord blood stem cells segment is likely to hold the largest share of the market in 2022. The Asia Pacific cryopreservation equipment market, based on end user, is segmented into stem cell banks, biotechnology and pharmaceuticals organizations, stem cell research laboratories, and others. The biotechnology and pharmaceuticals organizations segment is expected to hold the largest market share in 2022. On the basis of country, the market is further segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Japan is expected to hold the largest share of the market in 2022.  

Antech Group Inc.; Avantor, Inc.; BioLife Solutions; Brooks Automation, Inc; Cryofab; Cryoport Systems, LLC.; Danaher Corporation; Gold Sim Cellular Science LLC; Hamilton Company; PHC Holdings Corporation; Thermo Fisher Scientific Inc.; and ZhongkeMeiling Cryogenics Company Limited are among the leading companies in the Asia Pacific cryopreservation equipment market.